Recently, another mechanism for P-gp inhibition has been demonstrated: in cancer cells, hydroxychloroquine inactivates P-gp located in lysosomes by increasing lysosomal pH (after 12 h of incubation), thus sensitising cells to chemotherapeutic P-gp substrates such as doxorubicin [43]. Here, PGP is linked to cancer.